3i Group Share Price Hits 52-Week Low Ahead of Action Seminar

3i Group Share Price Hits 52-Week Low Ahead of Action Seminar

March 20, 2026

London, March 20, 2026, 22:29 GMT

3i Group, a constituent of the FTSE 100, finished Friday at 2,701 pence—its lowest close in a year—after dropping 2.28%. The shares lagged behind a sharply weaker London market, landing at the bottom of their 12-month range.

The recent slide is notable: 3i shares have slipped about 10.6% since the close on March 17. At this point, the stock sits roughly 9.4% under the post-dividend NAV of 2,980.5 pence that was reported for Dec. 31. For investment firms like this, NAV—net asset value—serves as a basic gauge of the portfolio’s worth after subtracting debt.

This comes at a tricky moment. 3i’s Action Capital Markets Seminar lands on March 26, with the company promising that’s when investors will hear more about Action’s 2025 results, plus the outlook for 2026.

FTSE 100 shed 1.4% in London on Friday, notching its third week of declines as stubbornly high oil prices and a more hawkish Bank of England stoked fresh rate jitters. The BoE kept its benchmark at 3.75% on Thursday. Traders are pricing in roughly a 70% shot at a hike in April. “The Bank cannot afford to fight a battle on two fronts,” said Nick Saunders, Webull UK CEO. Danni Hewson at AJ Bell flagged the risk of “another inflation burn.” Reuters

The context isn’t ideal for 3i, given how heavily it leans on Action. As of Dec. 31, 3i’s 62.3% stake in the discount retailer was valued at 22.382 billion pounds, making up roughly 74% of its total 30.309 billion pound portfolio. Action’s like-for-like sales—stores open at least a year—climbed 6.1% in the first four weeks of 2026, 3i reported.

Back in January, Chief Executive Simon Borrows called for “another strong year of compounding growth” at 3i. Still, Action’s performance keeps jolting the stock. Shares popped 8.8% on Jan. 29 after 3i posted its third-quarter update and climbed another 10% on Jan. 21, triggered by UBS data showing a rebound in France sales. 3i

It wasn’t just 3i taking a hit. Shares of Intermediate Capital Group dropped 3.5% on Friday, while Bridgepoint Group slipped 2.33%. Investors appeared to be cutting back on listed private-markets names across the board.

The risk stands out. If next week’s Action seminar delivers a clear message, the stock might find some footing. But if there’s even a hint that growth is losing steam as rate worries resurface, shares could stay under pressure.

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • CSL (ASX:CSL) Down 27% YTD as Health Sector Lags Broader Market
    July 9, 2026, 12:05 AM EDT. CSL Ltd (ASX:CSL) shares are off 26.9% so far in 2025. The biotech posts reliable dividends and generates steady healthcare revenue, but hasn't escaped the sector's rough patch. Its plasma, vaccine and renal units remain core. Healthcare has trailed the broader S&P/ASX200 over five years, even as US health spending is expected to grow 7% annually through 2027. Investors looking at ethical and sustainability factors keep backing the sector. CSL's dividend yield remains a key metric for returns while the stock stays volatile, so valuation is still in focus.